ASCO: Adding Pembrolizumab to Chemo Improves Survival in Cervical Cancer

THURSDAY, June 1, 2023 -- For women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progression-free survival, according to a study...